webinar email headers – 2025-10-13T135143.582

Senior Dog Arthritis: 6 Non-Invasive Pain Relief Solutions for Veterinarians 

Based on the webinar presented by Jane McNae BVSc, MANZCVS, MRCVS, PGCert, CCRT, Dip AnPhys, FHEA*

Osteoarthritis affects 80% of dogs by age eight, but surgery and heavy sedation aren’t your only options. Dr. Jane McNae, BVSc, MANZCVS, MRCVS, PGCert, CCRT, Dip AnPhys, FHEA, a veterinary physiotherapy specialist practicing in Hong Kong, shares her proven non-invasive approaches that help senior pets live comfortably without scalpels or sedation – and how they can transform your practice revenue. 

“What I really want to show you today is how in general practice, you can utilize a lot of these non-invasive pain fixes to help your pets.” – Dr. McNae 

Why Non-Invasive Arthritis Treatment Works Better Than Surgery

Unlike humans where osteoarthritis typically affects those over 55, our veterinary patients face a different timeline. According to the American Animal Hospital Association, one in five dogs suffers from osteoarthritis by just one year of age. By eight years old, that number jumps to 80% of dogs, with cats showing similarly high percentages. 

Dr. McNae’s Hong Kong practice operates entirely without “sharp objects” – no scalpels, no sedation – proving that effective canine arthritis management doesn’t require invasive procedures while maintaining excellent client satisfaction and practice profitability. 

Understanding Chronic Pain Management

The key to successful dog arthritis treatment lies in understanding the pain pathway. Pain signals travel from nociceptors (transduction) through the spinal cord (transmission and modulation) to the brain (perception). 

The critical distinction: While acute pain serves a protective purpose, chronic osteoarthritis pain becomes maladaptive – offering no benefit while significantly impacting quality of life. This is where targeted, non-invasive veterinary pain management interventions make the biggest difference. 

Case Study: Charlie's Transformation Through Non-Invasive Care

Charlie, a nine-year-old Labrador, presented with classic dog joint pain symptoms: slow walking, dragging his left hind foot, and obvious stiffness. Dr. McNae always videos pets walking, finding this helps clients clearly see the pain and understand the need for intervention. 

Through her non-invasive pet pain management protocol, Charlie progressed from a stiff, uncomfortable dog to a happy, mobile senior enjoying his golden years. 

See how non-invasive treatments can reduce your surgery referrals by 40%. Learn more about Assisi LOOP® therapy, which utilizes targeted Pulsed Electromagnetic Field (tPEMF™) technology to transform arthritis treatment outcomes. 

Dr. McNae's Six-Modality Approach to Non-Invasive Pain Relief

Dr. McNae’s approach focuses on client education and empowerment while building practice revenue through effective, repeatable treatments. Her protocol combines six different modalities, with Zomedica’s innovative solutions serving as the cornerstone of her treatment success. 

Treatment Comparison: Non-Invasive vs Traditional Approaches

Assisi LOOP® Targeted PEMF (tPEMF™) Therapy: The Gold Standard for Pet Pain Relief

The research-backed choice: Assisi Loop® targeted PEMF Therapy 

Energy type: Pulsed electromagnetic field  

How it works: Dr. McNae explains to clients that tPEMF “uses the body’s own natural anti-inflammatory processes.” The technology induces the nitric oxide cycle, producing anti-inflammatory molecules that promote circulation, reduce pain and swelling, and speed recovery. 

Clinical Advantages Over Traditional Arthritis Treatment

Pain pathway targeting: The Assisi LOOP tPEMF therapy works on both transduction and transmission pain pathways by normalizing blood flow, increasing lymphatic flow, and reducing prostaglandins. 

Evidence-based results: Dr. McNae emphasizes choosing research-backed solutions: “There’s a lot of different PEMF available on the market now. For me, it’s about where the research is and not all of those are research-based and not all of those are tested in animals.” 

She specifically references Dr. Leilani Alvarez’s placebo-controlled trials at New York Animal Medical Center as pivotal in her decision to incorporate Assisi LOOP therapy, calling it “the gold standard in pulsed electromagnetic field.” 

Implementation for Veterinary Practices

Treatment protocol for optimal results: 

  • Frequency: 3-4 times daily initially, typically reducing to 2 times daily 
  • Duration: 15 minutes per session 
  • Placement: Under pet’s bedding or during relaxed periods 
  • Safety: Completely safe alongside prescription medications 

Client empowerment advantage: “The best thing I love about the Assisi LOOP and the Assisi LOOP® Lounge is that I can send it home with the client and it empowers them to make decisions about their pet,” Dr. McNae explains. This home-use capability helps clients feel actively involved in their pet’s care while generating ongoing practice revenue. 

ROI for practices: Home-use devices create recurring revenue streams while improving client satisfaction and treatment compliance. 

Real-World Assisi LOOP Therapy Success Stories

Dr. McNae’s diverse caseload demonstrates the versatility of Assisi LOOP tPEMF therapy: 

Momo: Neurological condition with grade one disc pain managed with Assisi LOOP therapy  
Chocolate: Post-surgical pain and swelling after femoral head and neck excision  
Charlie: Brachial nerve plexus injury managed entirely via Zoom consultations  
Chewy (Cockatoo): Neuropraxia and tissue swelling from tight leg ring  
IBD Cat: Inflammatory bowel disease management using anti-inflammatory properties Momo (Cart Dog): Four-limb joint collapse in Cushing’s dog using Assisi LOOP Lounge three times daily 

Advanced Shockwave Technology for Veterinary Pain Management

The breakthrough: PulseVet® Shock Wave Therapy 

Energy type: Pressure waves of sound energy (similar to thunder following lightning) 

How it works: Sound energy penetrates deeply through water-based body tissues, creating compressive and tensile forces at tissue interfaces. This triggers cellular release of cytokines and growth factors that stimulate healing. 

Clinical Benefits That Exceed Traditional Methods

Measurable improvements: 

  • Increased blood flow and reduced inflammation 
  • Stimulates bone morphogenic proteins for bone healing 
  • Improves tendon and ligament healing through fiber alignment 
  • Provides temporary analgesic effect lasting days to weeks 

Dr. McNae’s integration strategy: “I bought shockwave into the practice three years ago when the PulseVet® system from Zomedica finally was able to release an X-Trode™.” The X-Trode technology dissipates peak energy, making treatments comfortable without sedation. 

Treatment Protocol for Maximum Effectiveness

Professional treatment schedule: 

  • Sessions: 2-3 treatments, two weeks apart 
  • Response time: Benefits appear within days 
  • Duration: Longer-lasting effects than other therapies 
  • Integration: Use after preparing tissues with other modalities 

Applications generating strong client outcomes: Excellent for tendons, ligaments, muscles, post-TPLO procedures, shoulder tendinopathies, bone healing, and multimodal osteoarthritis therapy. 

Why PulseVet Shock Wave Works Without Sedation

The revolutionary X-Trode technology makes PulseVet therapy unique in the shock wave market. By dissipating peak energy while maintaining therapeutic effectiveness, Dr. McNae can provide powerful treatments in her non-sedation practice. 

“This was the most recent addition to my practice. I’ve been waiting a long time to incorporate shock wave,” Dr. McNae explains. The ability to deliver focused shock wave therapy without sedation opens treatment possibilities for pets who aren’t surgical candidates. 

Ready to see PulseVet technology in action? Schedule a demonstration to discover how focused shock wave therapy takes pain control to the next level. 

Complementary Modalities in Dr. McNae's Protocol

Dr. McNae’s comprehensive approach includes additional modalities that work synergistically with Assisi Loop therapy and PulseVet shock wave: 

Therapeutic laser and photobiomodulation work excellently alongside tPEMF therapy, with Dr. McNae noting that combining laser with Assisi LOOP home therapy creates much faster response times. 

TENS therapy provides an additional electrical stimulation option for cases where other modalities may have limitations, often used in combination with Assisi LOOP therapy. 

Therapeutic ultrasound serves as another complementary option, particularly useful for recently clipped surgical patients when combined with the primary tPEMF and shock wave protocols.

The Future of Senior Pet Care Revenue

Dr. McNae’s practice demonstrates that effective osteoarthritis management doesn’t require invasive procedures while maintaining strong profitability. By combining evidence-based technologies like Assisi LOOP targeted PEMF therapy and PulseVet shock wave therapy with proper client education, veterinarians can offer comprehensive pain management that improves quality of life for senior pets and builds lasting client relationships. 

“If I can give them something that doesn’t make it all controlled by the veterinarian, but helping to empower them, I think it buys their compliance and their better understanding of how we’re trying to help the pet.” – Dr. McNae 

These non-invasive approaches offer hope for pets who aren’t surgical candidates and provide additional revenue streams for practices wanting to expand their pain management capabilities without major facility modifications. 

Transform your arthritis treatment outcomes today. Discover Assisi Loop® success stories and clinical applications to see how the gold-standard tPEMF technology empowers clients while building practice revenue. Explore PulseVet shock wave research and applications to learn how innovative shockwave technology is revolutionizing veterinary pain management. 

Ready to implement these proven protocols? Contact Zomedica’s veterinary specialists to develop a customized implementation plan for your practice, including training, support, and ROI projections. 

*Dr. McNae was paid by Zomedica, Inc. for her webinar presentation. Watch the webinar here. 

© 2025 Zomedica Inc. All rights reserved. PulseVet is a registered trademark of Zomedica Inc. 

Blog Banner for Website Content (43)

Shock Wave Therapy for Horses: Clinical Evidence for Lameness and Injury Treatment

Eighty-one percent of chronically lame horses unresponsive to conventional navicular treatment improved with shock wave therapy—and stayed sound beyond 12 months. 

That’s Dr. McClure’s peer-reviewed research, one of several studies Dr. Kim Keeton shared in her recent Zomedica webinar on equine shock wave therapy using PulseVet technology. Dr. Keeton brings 20 years of equine veterinary experience and 15+ years using PulseVet shock wave technology to her integrative practice outside Athens, Georgia. 

Why Electrohydraulic Technology Matters in Equine Shock Wave Therapy

PulseVet shock wave therapy deposits acoustic energy where tissue density changes—tendon-to-bone attachments, joint capsules, bone interfaces—triggering cytokine release that increases blood flow, stimulates neovascularization, and returns chronic conditions to an acute healing phase. 

The focal zone comparison: 

  • PulseVet’s electrohydraulic system: 140,000 mm³ tissue affected per pulse 
  • Electromagnetic devices: 61,000 mm³ 
  • Piezoelectric (linear trode): 2,476 mm³ 

Translation: You cover more tissue with fewer pulses. That means 1-3 treatments every 2-3 weeks instead of 4-8 weekly sessions required by piezoelectric systems. 

Dr. Keeton’s clinical pearl: “If you can see it on ultrasound, you can treat it with PulseVet shock wave therapy. Both use sound energy.” 

Shock Wave Therapy for Navicular Syndrome: 81% Improvement Rate

Dr. McClure’s study enrolled chronically lame horses that had already failed conventional treatment. These weren’t mild cases.  

Protocol: 2,000 pulses—1,000 through the frog, 1,000 through heel bulbs at E6 energy 

Results: 81% showed decreased lameness with no relapse beyond 12 months. 

Practice implication: You can offer clients a non-invasive alternative to neurectomy for one of equine medicine’s most frustrating chronic conditions. Zero complications reported across the study population. 

Tendon Injuries: Quality Matters More Than Speed

A 10-horse study (each horse serving as its own control) with collagenase-induced tendonitis demonstrated what Dr. Keeton calls the critical factor: PulseVet shock wave therapy improved the quality of tendon repair, not just healing speed. 

For performance horses, that quality differential determines reinjury risk. Suspensory ligament studies backed this up with measurable improvements in fiber alignment scores and echogenicity on ultrasound. 

Standard protocol: Three treatments at 3-week intervals.  

This makes equine shock wave therapy particularly valuable for sport horses where quality of repair determines return to competition. 

Osteoarthritis: Better Than Adequan in Head-to-Head Study

The 2009 carpal OA study compared three groups: placebo, polysulfated glycosaminoglycans (standard Adequan protocol: 7 doses over 28 days), and PulseVet shock wave therapy. 

Horses treated with PulseVet therapy showed significantly greater lameness improvement than both other groups. 

An earlier hock study (74 horses with tarsometatarsal and distal intertarsal OA) delivered 80% improvement rates: 

  • 38% improved one lameness grade 
  • 42% improved two grades 
  • Single treatment of 1,000-2,000 pulses 

Back Pain: 89% Success Rate, 3-5 Day Return to Work

“Rest does not help a chronic sore back heal,” Dr. Keeton stated bluntly, drawing the parallel to veterinarians’ own back pain experience. 

A 74-horse retrospective on PulseVet shock wave therapy for kissing spines and dorsal articular process inflammation showed 89% positive outcomes, with 60% maintaining improvement for 4-6 months. 

Why this matters mid-season: Horses rest just 2 days post-treatment, return gradually over 3-5 days. Your performance horse clients don’t lose weeks of competition preparation. 

Protocol: 2,000 pulses, single treatment using 35mm trode (midline for spinous processes) and 80mm trode (oblique angle for deeper dorsal articular processes) 

Wounds: When Everything Else Fails

Dr. Keeton presented “Doodlebug,” a 5-year-old Quarter Horse mare with biopsy-confirmed habronemiasis persisting over one year despite multiple surgical debridements, ivermectin, moxidectin, corticosteroids, and topical treatments. 

Dr. Hugh Worsham (Cumming, Georgia) administered two PulseVet shock wave treatments three days apart—just 500 pulses with the 5mm trode at lowest energy. 

The summer sore completely healed. 

Another case: a 6-month-old miniature horse with dog attack wounds, suspected clostridial infection, progressive necrosis, and copious purulent discharge. Three PulseVet shock wave treatments (days 5, 8, and 11 post-attack) produced substantial healing by day 32. 

The mechanism behind equine shock wave therapy for wounds: Increased blood flow enhances antibiotic penetration. Biofilm disruption tackles resistant infections. Cytokine release (VEGF, TGF-β, PCNA) drives neovascularization. 

Exercise-Induced Pulmonary Hemorrhage: Treating EIPH with Shock Wave Therapy

Dr. Beau Whitaker’s barrel racing study represents what Dr. Keeton called “one of the most exciting things coming out of PulseVet shock wave therapy”—treating exercise-induced pulmonary hemorrhage. 

Study: 21 barrel racers (13 had bled at their last race, 9 competed on Lasix) 

Results: 

  • Average BAL score dropped 1.5 grades 
  • 76% improved one grade minimum 
  • 47% improved two grades 

The insight: All horses had underlying equine asthma. The theory suggests asthma causes EIPH—PulseVet shock wave therapy addresses root pathology, not just symptoms. 

Research on PulseVet therapy for equine asthma is being extended through a Clinical Registry for Equine Asthma. 

Amplifying Your Orthobiologic Protocols

If you’re already using regenerative medicine in your equine practice, PulseVet shock wave therapy enhances results: 

PRP study findings: Shock wave application increased growth factor expression by 33-46% (TGF-β) and 190-219% (PDGF-ββ) compared to controls. 

Stem cell research: 500 pulses at low energy doesn’t damage mesenchymal stem cell proliferation or differentiation. Day-3 post-treatment showed increased ALPL indicating osteogenic effects potentially beneficial for fracture healing. 

Treatment Duration Reality

Dr. Keeton addressed the chronic condition question directly: Effects typically last 4-12 months before potential retreatment. This makes PulseVet shock wave therapy appropriate for long-term management, not just acute intervention. 

Why Major Equine Organizations Choose PulseVet Technology

PulseVet shock wave therapy serves as official ESWT for AQHA, NCHA, NRCHA, World Equestrian Center, US Equestrian, USEA, and USEF. That endorsement reflects 20 years of clinical research backing the technology. 

Two decades of equine shock wave therapy research show consistent findings: no serious complications, measurable improvement rates across multiple conditions, and fewer treatments required than alternative systems.  

*Dr. Keeton is an employee of  Zomedica Inc. and was paid for her webinar presentation. Watch the webinar here. 

© 2025 Zomedica Inc. All rights reserved. PulseVet is a registered trademark of Zomedica Inc. 

    Register or sign in to access the PulseVet Training Guide

    Veterinary professionals must have an account to access the PulseVet Training Guide. Please sign in or register below.
    Where is your vet practice located?

    I understand that by cheking this box I am affirming under penality of perjury, that I am a veterinary professional.

    Thank you

    Check your email for instructions on activating your account and accessing the PulseVet Training Guide.
    thanks-tic-128